Adaptive intensity-modulated radiotherapy with simultaneous integrated boost for stage III non-small cell lung cancer: Is a routine adaptation beneficial?

CONCLUSIONS: We demonstrated that the routinely adaptive SIB-IMRT strategy could significantly reduce the dose to surrounding normal tissues, potentially lower the associated acute RP and RE, without increasing the risk of tumor recurrences.PMID:33636232 | DOI:10.1016/j.radonc.2021.02.019

Source: Radiotherapy and Oncology : journal of the European Society for Therapeutic Radiology and Oncology - February 26, 2021 Category: Radiology Authors: Yinnan Meng Wei Luo Hailing Xu Wei Wang Suna Zhou Xingni Tang Zihong Li Chao Zhou Haihua Yang Source Type: research